| Makale Türü | Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale) | ||
| Dergi Adı | ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (Q1) | ||
| Dergi ISSN | 1382-6689 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 08-2022 |
| Cilt / Sayı / Sayfa | 94 / 6 / 103902–0 | DOI | 10.1016/j.etap.2022.103902 |
| Makale Linki | http://dx.doi.org/10.1016/j.etap.2022.103902 | ||
| Özet |
| This study aimed to determine the effects of UGT2B7 rs7662029 and rs7439366 polymorphisms on plasma buprenorphine (BUP) concentration and different treatment responses in a sample of 109 patients with opioid use disorder (OUD) treated with sublingual BUP/naloxone. Polymorphisms were analysed by PCR-RFLP. Plasma concentrations of BUP and its metabolite norbuprenorphine were detected by LC–MS/MS. Craving, withdrawal, depression and anxiety were measured by appropriate scales. OUD patients with rs7439366 CC or rs7662029 GG genotypes had significantly lower dose-normalized (BUP/D) and dose/kg-normalized BUP (BUP/D.kg-1) levels than those who were CT or AA carriers. Significant associations between UGT2B7 rs7662029 and increased craving (p = 0.037) and withdrawal symptoms (p = 0.029) were detected. Our findings were pointing to an important role of UGT2B7 in the … |
| Anahtar Kelimeler |
| UGT2B7 variation | Heroin addiction | Buprenorphine | PCR-RFLP |
| Atıf Sayıları | |
| Web of Science | 7 |
| Google Scholar | 9 |
| Dergi Adı | Environmental Toxicology and Pharmacology |
| Yayıncı | Elsevier B.V. |
| Açık Erişim | Hayır |
| ISSN | 1382-6689 |
| E-ISSN | 1872-7077 |
| CiteScore | 7,9 |
| SJR | 1,064 |
| SNIP | 0,936 |